What does “PSG 203094” mean for cobicistat?
“PSG 203094” appears to refer to an FDA Product-Specific Guidance (PSG) document tied to a specific drug product. To identify the exact PSG for cobicistat, you need the full FDA reference (the exact PSG title, company/product name, and whether it’s for an ANDA, NDA, 505(b)(2), or biologics pathway), because “cobicistat” can appear in multiple products and labeling contexts.
Where to find the FDA product-specific guidance for cobicistat
To locate the correct PSG entry, search the FDA PSG catalog using:
- The PSG number (203094)
- The active ingredient (cobicistat)
- The product name (if you have it)
- The application/approval type (if you know it)
Once you open the specific PSG record, it will usually list the product(s) and the regulatory expectations the FDA sets for that product.
What FDA PSG documents typically cover (so you know what to look for)
FDA product-specific guidance documents commonly address the evidence needed for approval and how FDA expects applicants to handle items like:
- Clinical or nonclinical data expectations
- Labeling and formulation considerations
- Study types and endpoints FDA expects
- Product-specific chemistry, manufacturing, and controls considerations
- Bioavailability/bioequivalence expectations when relevant
The exact contents depend on the specific PSG record tied to that PSG number.
If you meant a different FDA document than “PSG 203094”
There are also several other FDA guidance databases and document types (drug labeling guidance, drug development guidance, regulatory review guidance, etc.). If you can paste the exact text around “203094” (or a link/screenshot or the product name tied to it), I can pinpoint what it is and summarize what the guidance requires.
Quick check: what details do you have?
If you share any one of the following, I can give a precise answer:
- The full PSG title as shown on FDA’s site
- The application type (NDA/ANDA/505(b)(2))
- The company name listed with PSG 203094
- The cobicistat product name (brand name or combination with another drug)
Sources: none provided in the prompt.